Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Harrell W. Chesson, Lauri E. Markowitz, Susan Hariri, Donatus U. Ekwueme & Mona Saraiya. (2016) The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model. Human Vaccines & Immunotherapeutics 12:6, pages 1363-1372.
Read now
Read now
Articles from other publishers (74)
François Lagacé, Kathleen D’Aguanno, Connor Prosty, Alexandra Laverde-Saad, Leila Cattelan, Lydia Ouchene, Sarah Oliel, Genevieve Genest, Philip Doiron, Vincent Richer, Abdulhadi Jfri, Elizabeth O’Brien, Philippe Lefrançois, Mathieu Powell, Linda Moreau, Ivan V. Litvinov, Anastasiya Muntyanu & Elena Netchiporouk. (2023) The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications. Journal of Cutaneous Medicine and Surgery.
Crossref
Crossref
Patrick A. Clay, Trevor D. Thompson, Lauri E. Markowitz, Donatus U. Ekwueme, Mona Saraiya & Harrell W. Chesson. (2023) Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States. Vaccine 41:14, pages 2376-2381.
Crossref
Crossref
Laura M King, Joseph A Lewnard & Linda M Niccolai. (2023) Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review. Open Forum Infectious Diseases 10:1.
Crossref
Crossref
Marzieh Hosseini Nia, Fatemeh Rahmanian, Mehdi Ghahartars & Roksana Janghorban. (2022) Sexual function and sexual quality of life in men with genital warts: a cross-sectional study. Reproductive Health 19:1.
Crossref
Crossref
Ronald Berna, David J. Margolis & John S. Barbieri. (2022) Annual Health Care Utilization and Costs for Treatment of Cutaneous and Anogenital Warts Among a Commercially Insured Population in the US, 2017-2019. JAMA Dermatology 158:6, pages 695.
Crossref
Crossref
Amrita Srivastava, Priyanka Namdev & Rajaneesh Anupam. 2022. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies
65
79
.
Elisabeth RB Becker, Ross Shegog, Lara S Savas, Erica L Frost, C Mary Healy, Stanley W Spinner & Sally W Vernon. (2021) Informing Content and Feature Design of a Parent-Focused Human Papillomavirus Vaccination Digital Behavior Change Intervention: Synchronous Text-Based Focus Group Study. JMIR Formative Research 5:11, pages e28846.
Crossref
Crossref
Elmar A. Joura, Angels Ulied, Corinne Vandermeulen, Milagrosa Rua Figueroa, Ilkka Seppä, Juan José Hernandez Aguado, Anitta Ahonen, Olaf Reich, Miia Virta, Antonino Perino, Merce Peris Tuser, Klaus Peters, Massimo Origoni, Francesco Raspagliesi, Wiebren A.A. Tjalma, Philippe Tummers, Linn Woelber, Pekka Nieminen, Pierre van Damme, Jalid Sehouli, Gabriel Fiol Ruiz, Sara Brucker, Tanja Fehm, Kyeongmi Cheon, Sonali Rawat, Alain Luxembourg & Frederick Wittke. (2021) Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study. Vaccine 39:20, pages 2800-2809.
Crossref
Crossref
Rayleen M. Lewis, Jean-François Laprise, Julia W. Gargano, Elizabeth R. Unger, Troy D. Querec, Harrell W. Chesson, Marc Brisson & Lauri E. Markowitz. (2021) Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United States. Sexually Transmitted Diseases 48:4, pages 273-277.
Crossref
Crossref
Kiameesha R. Evans & Michael K. Gusmano. (2021) Civic Learning, Science, and Structural Racism. Hastings Center Report 51:S1.
Crossref
Crossref
Harrell W. Chesson, Elissa Meites, Donatus U. Ekwueme, Mona Saraiya & Lauri E. Markowitz. (2020) Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model. Vaccine 38:50, pages 8032-8039.
Crossref
Crossref
Jose Carlos Truzzi, Ismael Dale Silva, Marcos Paulo Freire, Miguel Jorge Neto, Fabio Ferro Rodrigues, Gustavo Arantes Maciel, Ruana Girardi, Sissi Bertolini & Leonardo O. Reis. (2020) Contemporary human papillomavirus genotyping and correlations to peniscopy, cytology, and histopatology on over 1000 males. Diagnostic Cytopathology 48:11, pages 1021-1026.
Crossref
Crossref
Vera Prilepskaya, Mikhail Gomberg, Smita Kothari, Karen Yee, Amit Kulkarni, Suzanne Garland & Anna Giuliano. (2020) Estimating the Burden of Illness Related to Genital Warts in Russia: A Cross-Sectional Study. Journal of Health Economics and Outcomes Research, pages 182-188.
Crossref
Crossref
Lani Buenconsejo, Smita Kothari-Talwar, Karen Yee, Amit Kulkarni, Nuria Lara, Montserrat Roset, Anna R. Giuliano & Suzanne Garland. (2019) Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study. Infectious Agents and Cancer 14:1.
Crossref
Crossref
Anthony E. Yakely, Lital Avni-Singer, Carlos R. Oliveira & Linda M. Niccolai. (2019) Human Papillomavirus Vaccination and Anogenital Warts: A Systematic Review of Impact and Effectiveness in the United States. Sexually Transmitted Diseases 46:4, pages 213-220.
Crossref
Crossref
Laura Sichero, Anna R. Giuliano & Luisa Lina Villa. (2019) Human Papillomavirus and Genital Disease in Men: What We Have Learned from the <b><i>HIM Study</i></b>. Acta Cytologica 63:2, pages 109-117.
Crossref
Crossref
Demaretta S. Rush & Edward J. Wilkinson. 2019. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
1
64
.
Kristina R. Dahlstrom, Shuangshuang Fu, Wenyaw Chan, Zeena Shelal, Lois M. Ramondetta & David R. Lairson. (2018) Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients. PharmacoEconomics 36:11, pages 1355-1365.
Crossref
Crossref
Vieri Grandi, Maurizio Sessa, Luigi Pisano, Riccardo Rossi, Arturo Galvan, Riccardo Gattai, Moira Mori, Luana Tiradritti, Stefano Bacci, Giuliano Zuccati, Pietro Cappugi & Nicola Pimpinelli. (2018) Photodynamic therapy with topical photosensitizers in mucosal and semimucosal areas: Review from a dermatologic perspective. Photodiagnosis and Photodynamic Therapy 23, pages 119-131.
Crossref
Crossref
Sarah Feldman. (2018) A Few More Reasons to Vaccinate Against Human Papillomavirus. Obstetrics & Gynecology 132:2, pages 259-260.
Crossref
Crossref
Harrell W. Chesson, Elissa Meites, Donatus U. Ekwueme, Mona Saraiya & Lauri E. Markowitz. (2018) Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States. Vaccine 36:29, pages 4362-4368.
Crossref
Crossref
Michael Daugherty & Timothy Byler. (2018) Genital Wart and Human Papillomavirus Prevalence in Men in the United States From Penile Swabs: Results From National Health and Nutrition Examination Surveys. Sexually Transmitted Diseases 45:6, pages 412-416.
Crossref
Crossref
Rachel Dawson, Keith Lemmon, Nidhi J. Trivedi & Shana Hansen. (2018) Improving human papilloma virus vaccination rates throughout military treatment facilities. Vaccine 36:11, pages 1361-1367.
Crossref
Crossref
Demaretta Rush & Edward J. Wilkinson. 2018. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
1
65
.
Marta García-Yuste González, Ana Maria Muñoz Ledesma, Mayte Navarro Monge & José Schneider Fontán. 2017. Colposcopy and Cervical Pathology. Colposcopy and Cervical Pathology.
Taek Sang Lee, Smita Kothari-Talwar, Puneet K Singhal, Karen Yee, Amit Kulkarni, Nuria Lara, Montserrat Roset, Anna R Giuliano, Suzanne M Garland & Woong Ju. (2017) A cross-sectional study estimating the burden of illness related to genital warts in South Korea. BMJ Open 7:6, pages e014217.
Crossref
Crossref
Tsen-Fang Tsai, Smita Kothari-Talwar, Karen Yee, Amit Kulkarni, Nuria Lara, Montserrat Roset, Anna R. Giuliano & Suzanne M. Garland. (2017) Estimating the burden of genital warts in Taiwan. Sexual Health 14:6, pages 485.
Crossref
Crossref
Deanna Kepka, Qian Ding, Amy J. Hawkins, Echo L. Warner & Kenneth M. Boucher. (2016) Factors associated with early adoption of the HPV vaccine in US male adolescents include Hispanic ethnicity and receipt of other vaccines. Preventive Medicine Reports 4, pages 98-102.
Crossref
Crossref
J. Chanal, S. Fouéré, F. Yassir-Oria, N. Spenatto, F. Bouscarat, E. Picot, P. Martinet, C. Vernay-Vaisse, F. Pelletier, C. Courtieu, V. Baclet, C. Bernier, D. Aymar-Moulene, F. Dupuis-Fourdan, A. Passeron, C. Bara-Passot, A.-L. Pinault, L. Misery, M. Janier & N. Dupin. (2016) CONDYDAV : étude observationnelle multicentrique des patients présentant des condylomes dans les dispensaires antivénériens en France. Annales de Dermatologie et de Vénéréologie 143:11, pages 675-681.
Crossref
Crossref
Louise K. Andersen & Mark D. P. Davis. (2016) Sex differences in the incidence of skin and skin‐related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide. International Journal of Dermatology 55:9, pages 939-955.
Crossref
Crossref
Eileen M. Burd & Christina L. Dean. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
177
195
.
Eileen M. Burd & Christina L. Dean. (2016) Human Papillomavirus. Microbiology Spectrum 4:4.
Crossref
Crossref
Elizabeth Thurgar, Samantha Barton, Charlotta Karner & Steven J Edwards. (2016) Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technology Assessment 20:24, pages 1-486.
Crossref
Crossref
Marc Brisson, Jean-François Laprise, Harrell W. Chesson, Mélanie Drolet, Talía Malagón, Marie-Claude Boily & Lauri E. Markowitz. (2015) Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States. Journal of the National Cancer Institute 108:1, pages djv282.
Crossref
Crossref
Ina U. Park, Camille Introcaso & Eileen F. Dunne. (2015) Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clinical Infectious Diseases 61:suppl 8, pages S849-S855.
Crossref
Crossref
Cornelia L Trimble, Matthew P Morrow, Kimberly A Kraynyak, Xuefei Shen, Michael Dallas, Jian Yan, Lance Edwards, R Lamar Parker, Lynette Denny, Mary Giffear, Ami Shah Brown, Kathleen Marcozzi-Pierce, Divya Shah, Anna M Slager, Albert J Sylvester, Amir Khan, Kate E Broderick, Robert J Juba, Timothy A Herring, Jean Boyer, Jessica Lee, Niranjan Y Sardesai, David B Weiner & Mark L Bagarazzi. (2015) Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. The Lancet 386:10008, pages 2078-2088.
Crossref
Crossref
Sarah B. Bass, Amy Leader, Michelle Shwarz, Judith Greener & Freda Patterson. (2015) Correlates to Human Papillomavirus Vaccination Status and Willingness to Vaccinate in Low-Income Philadelphia High School Students. Journal of School Health 85:8, pages 527-535.
Crossref
Crossref
Marek Petráš & Věra Adámková. (2015) Rates and predictors of genital warts burden in the Czech population. International Journal of Infectious Diseases 35, pages 29-33.
Crossref
Crossref
N. I. Chernova, Yu. N. Perlamutrov, M. I. Bagaeva, V. A. Kucherov, S. V. Stovbun, E. V. Petryanina & D. Yu. Safronov. (2015) Capabilities of recurrent anogenital wart therapy. Klinicheskaya dermatologiya i venerologiya 14:4, pages 39.
Crossref
Crossref
Demaretta S. Rush & Edward J. Wilkinson. 2015. Vulvar Pathology. Vulvar Pathology
267
296
.
Cornelia L. Trimble. (2014) HPV Infection–Associated Cancers: Next-Generation Technology for Diagnosis and Treatment. Cancer Immunology Research 2:10, pages 937-942.
Crossref
Crossref
Allison L. Naleway, Sheila Weinmann, Brad Crane, Julianne Gee, Lauri E. Markowitz & Eileen F. Dunne. (2014) Evaluation of a Surveillance Case Definition for Anogenital Warts, Kaiser Permanente Northwest. Sexually Transmitted Diseases 41:8, pages 496-500.
Crossref
Crossref
Eloisa Llata, Mark Stenger, Kyle Bernstein, Sarah Guerry, Roxanne Kerani, River Pugsley, Preeti Pathela, Irina Tabidze & Hillard Weinstock. (2014) Prevalence of Genital Warts Among Sexually Transmitted Disease Clinic Patients—Sexually Transmitted Disease Surveillance Network, United States, January 2010 to December 2011. Sexually Transmitted Diseases 41:2, pages 89-93.
Crossref
Crossref
Linda R. Duska. (2014) Safety and Success of the Human Papillomavirus Vaccine: Time for a Robust Vaccination Program in the United States and Worldwide. Clinical Therapeutics 36:1, pages 4-7.
Crossref
Crossref
Sanjib Saha & Ulf G Gerdtham. (2013) Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review. Health Economics Review 3:1.
Crossref
Crossref
Rémi Marty, Stéphane Roze, Xavier Bresse, Nathalie Largeron & Jayne Smith-Palmer. (2013) Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 13:1.
Crossref
Crossref
Maria Michela Gianino, Sergio Delmonte, Emanuela Lovato, Morena Martinese, Sabrina Rondoletti, Maria Grazia Bernengo & Carla Maria Zotti. (2013) A retrospective analysis of the costs and management of genital warts in Italy. BMC Infectious Diseases 13:1.
Crossref
Crossref
Harshila Patel, Monika Wagner, Puneet Singhal & Smita Kothari. (2013) Systematic review of the incidence and prevalence of genital warts. BMC Infectious Diseases 13:1.
Crossref
Crossref
A.V. Kuznetsov, R.A. Müller, T. Ruzicka, T. Herzinger & L. Kuznetsov. (2013) Knowledge of sexually transmitted HPV infection, genitoanal warts, cancer and their prevention among young females after vaccine introduction in Germany. Journal of the European Academy of Dermatology and Venereology 27:12, pages 1527-1534.
Crossref
Crossref
Eileen F. Dunne & Ina U. Park. (2013) HPV and HPV-Associated Diseases. Infectious Disease Clinics of North America 27:4, pages 765-778.
Crossref
Crossref
Mandy A. Allison, Eileen F. Dunne, Lauri E. Markowitz, Sean T. O'Leary, Lori A. Crane, Laura P. Hurley, Shannon Stokley, Christine I. Babbel, Michaela Brtnikova, Brenda L. Beaty & Allison Kempe. (2013) HPV Vaccination of Boys in Primary Care Practices. Academic Pediatrics 13:5, pages 466-474.
Crossref
Crossref
Elaine W. FlaggRobert SchwartzHillard Weinstock. (2013) Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination. American Journal of Public Health 103:8, pages 1428-1435.
Crossref
Crossref
Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Eileen F. Dunne & Lauri E. Markowitz. (2013) Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States. Vaccine 31:37, pages 3899-3905.
Crossref
Crossref
Deepa R. Camenga, Eileen F. Dunne, Mayur M. Desai, Julianne Gee, Lauri E. Markowitz, Ajit DeSiliva & Nicola P. Klein. (2013) Incidence of Genital Warts in Adolescents and Young Adults in an Integrated Health Care Delivery System in the United States Before Human Papillomavirus Vaccine Recommendations. Sexually Transmitted Diseases 40:7, pages 534-538.
Crossref
Crossref
Marc Steben, Najwa Ouhoummane, Caroline Rodier & Paul Brassard. (2013) Temporal Trends in Genital Warts Among Individuals Covered by the Public Prescription Drug Insurance Plan in the Province of Quebec, Canada, From 1998 to 2007. Journal of Lower Genital Tract Disease 17:2, pages 147-153.
Crossref
Crossref
Peng-jun Lu, Walter W. Williams, Jun Li, Christina Dorell, David Yankey, Deanna Kepka & Eileen F. Dunne. (2013) Human Papillomavirus Vaccine Initiation and Awareness. American Journal of Preventive Medicine 44:4, pages 330-338.
Crossref
Crossref
Louise Baandrup, Maria Blomberg, Christian Dehlendorff, Carsten Sand, Klaus K. Andersen & Susanne K. Kjaer. (2013) Significant Decrease in the Incidence of Genital Warts in Young Danish Women After Implementation of a National Human Papillomavirus Vaccination Program. Sexually Transmitted Diseases 40:2, pages 130-135.
Crossref
Crossref
Baudelio GutierrezJrJr, Anthony Leung, Kevin Trimell Jones, Peter Smith, Randee Silverman, Ian Frank & Amy E. Leader. (2012) Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males. American Journal of Men's Health 7:1, pages 27-36.
Crossref
Crossref
Kruti P. Maniar, Brigitte M. Ronnett, Russell Vang & Anna Yemelyanova. (2013) Coexisting High-grade Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminatum. American Journal of Surgical Pathology 37:1, pages 53-60.
Crossref
Crossref
David Forman, Catherine de Martel, Charles J. Lacey, Isabelle Soerjomataram, Joannie Lortet-Tieulent, Laia Bruni, Jerome Vignat, Jacques Ferlay, Freddie Bray, Martyn Plummer & Silvia Franceschi. (2012) Global Burden of Human Papillomavirus and Related Diseases. Vaccine 30, pages F12-F23.
Crossref
Crossref
Marc Arbyn, Silvia de Sanjosé, Mona Saraiya, Mario Sideri, Joel Palefsky, Charles Lacey, Maura Gillison, Laia Bruni, Guglielmo Ronco, Nicolas Wentzensen, Julia Brotherton, You‐Lin Qiao, Lynnette Denny, Jacob Bornstein, Laurent Abramowitz, Anna Giuliano, Massimo Tommasino & Joseph Monsonego. (2012) EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease. International Journal of Cancer 131:9, pages 1969-1982.
Crossref
Crossref
Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Meg Watson, Douglas R. Lowy & Lauri E. Markowitz. (2012) Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 30:42, pages 6016-6019.
Crossref
Crossref
G. M. Anic, J.-H. Lee, L. L. Villa, E. Lazcano-Ponce, C. Gage, R. Jose C. Silva, M. L. Baggio, M. Quiterio, J. Salmeron, M. R. Papenfuss, M. Abrahamsen, H. Stockwell, D. E. Rollison, Y. Wu & A. R. Giuliano. (2012) Risk Factors for Incident Condyloma in a Multinational Cohort of Men: The HIM Study. Journal of Infectious Diseases 205:5, pages 789-793.
Crossref
Crossref
Adam J.N. Raymakers, Mohsen Sadatsafavi, Fawziah Marra & Carlo A. Marra. (2012) Economic and Humanistic Burden of External Genital Warts. PharmacoEconomics 30:1, pages 1-16.
Crossref
Crossref
Elissa Meites, Eloisa Llata, Susan Hariri, Jonathan Zenilman, Lisa Longfellow, Jane Schwebke, Irina Tabidze, Christie Mettenbrink, Heidi Jenkins, Sarah Guerry, Preeti Pathela, Lenore Asbel, Jeffrey A. Stover, Kyle Bernstein, Roxanne P. Kerani, Eileen F. Dunne & Lauri E. Markowitz. (2012) HPV Vaccine Implementation in STD Clinics—STD Surveillance Network. Sexually Transmitted Diseases 39:1, pages 32-34.
Crossref
Crossref
. (2012) The value of HPV vaccination. Nature Medicine 18:1, pages 28-29.
Crossref
Crossref
Gabriella M. Anic, Ji–Hyun Lee, Heather Stockwell, Dana E. Rollison, Yougui Wu, Mary R. Papenfuss, Luisa L. Villa, Eduardo Lazcano-Ponce, Christine Gage, Roberto José C. Silva, Maria L. Baggio, Manuel Quiterio, Jorge Salmerón, Martha Abrahamsen & Anna R. Giuliano. (2011) Incidence and Human Papillomavirus (HPV) Type Distribution of Genital Warts in a Multinational Cohort of Men: The HPV in Men Study. The Journal of Infectious Diseases 204:12, pages 1886-1892.
Crossref
Crossref
Mélanie Drolet, Marc Brisson, Elizabeth Maunsell, Eduardo L. Franco, François Coutlée, Alex Ferenczy, Sam Ratnam, William Fisher & James A. Mansi. (2011) The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study. Sexually Transmitted Diseases 38:10, pages 949-956.
Crossref
Crossref
Gabriella M. Anic & Anna R. Giuliano. (2011) Genital HPV infection and related lesions in men. Preventive Medicine 53, pages S36-S41.
Crossref
Crossref
Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Eileen F. Dunne & Lauri E. Markowitz. (2011) The cost-effectiveness of male HPV vaccination in the United States. Vaccine 29:46, pages 8443-8450.
Crossref
Crossref
Eileen F. Dunne, Maya Sternberg, Lauri E. Markowitz, Geraldine McQuillan, David Swan, Sonya Patel & Elizabeth R. Unger. (2011) Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States—National Health and Nutrition Examination Survey, 2003–2006: Opportunity to Measure HPV Vaccine Impact?. The Journal of Infectious Diseases 204:4, pages 562-565.
Crossref
Crossref
Jane J. Kim. (2011) Weighing the Benefits and Costs of HPV Vaccination of Young Men. New England Journal of Medicine 364:5, pages 393-395.
Crossref
Crossref
Jane J Kim. (2010) Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. The Lancet Infectious Diseases 10:12, pages 845-852.
Crossref
Crossref
Thomas W. Weiss, Gregory D. Zimet, Susan L. Rosenthal, Susan K. Brenneman & Jonathan D. Klein. (2010) Human Papillomavirus Vaccination of Males: Attitudes and Perceptions of Physicians Who Vaccinate Females. Journal of Adolescent Health 47:1, pages 3-11.
Crossref
Crossref